The global visual health event Vision China 2025 successfully concluded on June 15, 2025 at the Xi’an International Conference Center. Akeso made a strong appearance at the event, presenting its globally leading OptiDynamic™ AI photolithography personalized myopia management solution and MetaRx™ super-lens photolithography human-eye optical lens processing technology, helping to ignite a new wave of innovation in myopia prevention and control.

During the exhibition, Akeso’s Evosight Flip™ (Optical Far-Sight Reading Device) and Evosight Desk™ (AR Far-Sight Display) allowed numerous families to experience the “power of light.” These solutions are designed to make reading and screen use feel as though the eyes are looking farther away rather than at close range, helping reduce eye strain and support healthier visual habits, especially for children.

3 Core Technologies That Led Ophthalmology Experts to Call Them “Disruptive”

1. OptiDynamic™ AI Photolithography Myopia Management Solution (Global First Launch)

Akeso’s OptiDynamic™ photolithography personalized myopia management solution was officially unveiled at Vision China 2025. The solution is built around an AI-driven digital design framework centered on the process of perception, decision-making, and execution. By deeply integrating Akeso’s MetaRx™ super-lens photolithography technology, it enables dynamic adaptation of lens optical zones to pupil size, customized small optical zones, and high-defocus designs.

This approach breaks through the limitations of traditional myopia prevention and control methods and provides children with high myopia a solution that is powerful, comfortable, precise, and personalized.

Four Core Breakthroughs

• Personalized Lens Design (Customized Small Optical Zones)
  By integrating MetaRx™ ultra-precision photolithography technology, joint development with authoritative ophthalmology institutions, and ongoing clinical research conducted in medical institutions, this solution builds trust through the combination of advanced engineering and evidence-based medicine.
• Pupil Strategy Control Breakthrough (Comfortable High Defocus)
  The solution adopts 0.05 mm retinal cell-level microlenses, which are one twentieth the size of traditional designs. It enables dynamic defocus adjustment of up to ±10 diopters and achieves a 90 percent ultra-high effective fill rate, delivering exceptional comfort even under high defocus conditions.
• Pupil Strategy Control Barrier (Powerful All-in-One Regulation)
  Through synergistic dynamic regulation of defocus, aberration, and contrast, the solution covers approximately 90 percent of individual differences while reducing the risk of treatment resistance.
• Pupil Strategy Control Innovation (Thinner and More Pressure-Relieving)
  By combining 1.67 and 1.74 high-index resin with nano-photolithography microstructures, the solution addresses the longstanding challenge of balancing lens thickness with therapeutic effectiveness. It also includes a complimentary personalized redesign guarantee service.

2. MetaRx™ Super-Lens Photolithography Lens Technology (Disrupting Traditional Manufacturing)

MetaRx™ was introduced as the world’s first super-lens photolithography technology specifically designed for human-eye optical lenses.

• Precision Processing
  The technology achieves overlay accuracy of 1 micrometer, a minimum line width of 50 nanometers in the XY direction and 300 nanometers in the Z direction, splicing accuracy of 200 nanometers, and positioning accuracy of 100 nanometers, meeting the requirements of ultra-high precision optical manufacturing.
• Customizable Design and Flexible Processing
  The platform supports JPG, PNG, and STL formats, allows flexible adjustment of channels and dimensions, and supports personalized parallel processing.
• High Speed and High Efficiency
  The maximum scanning speed reaches 5,000 millimeters per second, with a high-precision mode of 1,000 millimeters per second. Multi-focus parallel printing significantly improves production efficiency.
• Complex Structure Support
  The technology supports two-dimensional, three-dimensional, and multi-layer micro and nano structures, including grayscale lithography and periodic arrays, making it suitable for optical components and MEMS devices.

3. XR+ Far-Image Light Field Technology (Addressing the Challenge of Near-Distance Eye Use)

• Evosight Flip (Optical Far-Sight Reading Device)

This solution applies an innovative optical design that combines fractional mirrors with free-form total internal reflection mirrors. Through physical distance extension technology, reading materials are virtually imaged at distances ranging from 3 to 20 meters.

When combined with dot contrast control technology using precise ten-thousand-point matrix arrangements, the system significantly reduces retinal light stimulation and accurately suppresses abnormal axial elongation. The platform features a 19.6-inch ultra-wide field of view, three-level adjustable full-spectrum lighting, and an ergonomic design that improves both the visual environment and sitting posture.

• Evosight Desk (AR Far-Sight Display)

Using a patented AR free-form optical solution, the screen image is equivalently enlarged to a 200-inch display viewed from a distance of six meters, helping to reduce eye fatigue caused by prolonged near-distance viewing.

An imported retina-level display with high color reproduction, low distortion, and blue-light protection is combined with circular polarization technology to effectively relieve dry eye symptoms and visual fatigue, providing innovative protection for adolescent eye health.

Following the conclusion of Vision China 2025 in Xi’an, Akeso demonstrated a comprehensive innovation ecosystem that integrates artificial intelligence, precision optical manufacturing, and far-image light field technology. By translating advanced optical science into practical, family-oriented eye health solutions, Akeso continues to advance myopia prevention and control toward greater precision, personalization, and evidence-based clinical application.

9^th “Love Light” Ophthalmology Specialist Committee Conference Held Alongside Vision China 2025

To promote technological innovation and academic exchange in the field of vision and optics and to advance myopia prevention and personalized lens solutions, the sub-venue titled “New Technology, New Vision, New Future: The Ninth ‘Love Light’ Optical Lens Academic Conference and the Cross-Strait Medical and Health Exchange Association Ophthalmology Specialist Committee Refractive Issues and Prevention Working Group 2025 Annual Academic Conference” was successfully held on the afternoon of June 13, 2025. The meeting took place during Vision China 2025.

The conference was organized by the Cross-Strait Medical and Health Exchange Association Ophthalmology Specialist Committee, co-organized by the Vision China 2025 Organizing Committee and the Asia Optometric Management Academy (AOMA), and supported by Akeso and Weishi Aikent (Guangdong) Medical Technology Joint Stock Company.

The meeting gathered renowned experts, scholars, and industry representatives from the domestic vision and optics field to conduct in-depth discussions and exchanges on cutting-edge topics including new technologies for myopia prevention and control, innovative optical lens design, and personalized management practices.

1. Expert Presentations on Emerging Technologies and Clinical Practice in Myopia Prevention

The conference opening was jointly hosted by Professor Hu Liang and Professor Lin Na of the Affiliated Eye Hospital of Wenzhou Medical University. Professor Lv Fan of the Affiliated Eye Hospital of Wenzhou Medical University delivered the opening remarks.

The subsequent special report sessions were rich and varied; as mentioned below.

• Professor Xu Meiping of the Affiliated Eye Hospital of Wenzhou Medical University presented “A Test of Sharpness: Rigorous Clinical Promotion of Early-Stage Myopia Prevention with Ai Muhao RuiGuard,” sharing clinical practice experience in promoting early intervention for myopia management.
• Professor Li Yiyu presented “Ten Years of Sharpening a Sword: How a Domestic Design Engine Supports Customized Lens Product Innovation,” exploring how domestic design capabilities are empowering customized lens product innovation.
• Dr. Cai Xiaogu (Akeso) introduced “Optical Microcraftsmanship: How MetaRx™ Photolithography Technology Promotes a Global Precision Revolution in Myopia Prevention and Control,” presenting the application prospects of MetaRx™ photolithography in advancing precision myopia prevention and control.
• Professor Zou Haidong of the Shanghai Eye Disease Prevention and Control Center delivered “Axial Analysis: An In-depth Interpretation of Myopia Prevention and Control Consensus from the Perspective of Axial Monitoring,” offering a detailed analysis of prevention and control consensus through axial length monitoring.
• Professor Yang Xiao of Zhongshan Ophthalmic Center, Sun Yat-sen University, shared “Craftsmanship Practice: Practical Experience and Innovative Insights on Personalized Myopia Prevention and Control Management,” discussing hands-on experience and innovative thinking in personalized myopia control.

2. Panel Discussion on Integrating Optical Technology with Clinical Myopia Management

With the continuous development of new technologies, clinicians now have greater ability to deliver precise, personalized myopia management solutions. These advancements make it possible to better understand each child’s individual visual needs and to design prevention strategies that are more accurately tailored to them.

The roundtable discussion titled “Thoughts on Optical Technology Innovation and Medical Integration in Personalized Lens Solutions” focused on optical technology innovation and its integration with medicine in the context of personalized lens solutions. The discussion explored how to enhance routine personalized customization capabilities. During this forward-looking roundtable, the experts exchanged perspectives as follows.

• Moderator Dr. Chen Jiawei opened by stating that myopia prevention required collective expert input to provide clinical reference for practitioners.
• Professor Zou Haidong observed that populations who were more aware of myopia prevention and who placed higher importance on it also tended to show greater individual concern, which was related to future myopia control outcomes.
• Professor Lan Weizhong pointed out that people with the same diopter could have very different defocus state distribution patterns, sometimes markedly different, and emphasized that a one-person, one-lens approach was important.
• Professor Ye Lu noted that defocus imaging located closer to the macular region produced better defocus effects and could be considered when exploring personalized prevention strategies.
• Dr. Fan Zhicheng suggested that custom lenses could consider differences in pupil size and that it might be useful to attempt optical zone customization for frame lenses based on pupil size to explore improved myopia control effects.
• Professor Wang Kai emphasized that management in the early pre-myopia stage was also important and that options such as low-concentration atropine and plano frames could be considered.
• Professor Xiang Yan said there were many predictive methods for myopia prevention effectiveness, such as choroidal blood flow metrics, and genetic susceptibility could also be considered.
• Professor Deng Ruzhi affirmed that photolithography lenses could unquestionably provide a variety of personalized options.
• Professor Mao Xinjie, acting as the session summarizer, emphasized that personalization was not to be implemented in a disorderly way and that it required guidance and direction.

This was a meeting that brought together ideas, where experts shared how they had applied personalized methods in clinical practice to tailor prevention strategies for special patients. They discussed how differences in binocular visual function can affect myopia prevention outcomes and how lens design can be adjusted to improve treatment effectiveness.

To strengthen practitioners’ ability to develop personalized myopia management solutions, Dr. Cai Xiaogu announced that the course “Personalized Myopia Management and New Technology for Myopia Prevention and Control” would be launched in the near future. The course will be jointly developed by the Asia Optometric Management Academy (AOMA) and the China Ophthalmology Platinum Institute.

The program will bring together leading regional and domestic experts and frontline practitioners from across the Asia-Pacific region to develop its content. It will incorporate an international collaborative perspective, introduce innovative technologies, and present both classic and complex clinical cases to support professional development in personalized management and customization techniques.

Through this course, practitioners will gain a deeper understanding of the core principles and strategies of personalized myopia management, the integration of innovative technologies with evidence-based practice, and the application of individual difference assessments to deliver precise and effective myopia prevention solutions for each child. The initiative aims to inspire and empower professionals, promote the development of individualized prevention strategies summarized as “one eye, one plan,” and inject new momentum into the field of myopia prevention and control.

About Vision China

Vision China is one of the leading professional platforms for the ophthalmology and optometry industry, bringing together clinicians, researchers, academic institutions, and technology innovators. The event serves as a key venue for academic exchange, industry collaboration, and the presentation of cutting-edge advancements in eye health, optical technology, and clinical practice.

About Akeso

Akeso Eyecare is a doctor-founded eye-technology company and CDMO focused on improving vision care. We design and build advanced solutions like AR displays for myopia prevention, eye tracking, extended reality devices, and digital vision health tools used in eye care and smart technology.

Our mission is to improve global vision health through smart innovation. By combining optical design, materials science, and AI, our R&D team supports partners from early research to custom design, manufacturing, and large-scale production, always guided by medical expertise, collaboration, sustainability, and patient-first thinking.

Akeso – engineering the future of vision.

www.akesoeyecare.com